Centro Clinico Nemo — Clinical Trial Site

43 Registered trials

23 Currently recruiting

Organisation

Centro Clinico Nemo

Location

Milan, Italy

Identifier

ORG-100011251

Address

Via Paolo Richiedei 16, 25064, Italy

Departments

301: NEuroMuscular Omnicentre
ALS center
Centro Clinico NeMO
Centro Clinico Nemo - Brescia
Centro Clinico NeMO - Clinical Reasearch Center Phase I
Centro Clinico Nemo - Milan
Centro Clinico NeMO -MIlano
Centro clinico NEMO (NEuroMuscular Omnicentre)
Centro Clinico NeMO Ancona
Centro Clinico Nemo di Brescia
Centro clinico NeMO di Milano
Centro Clinico NeMO of Milano
Clinical Research Center Fase I
Dipartimento di Neurologia
Fondazione Serena Onlus - Centro Clinico NEMO - Clinic/Outpatient Facility
N/A
NA
Nemo Center in Milan
NeMO Clinical Center
Neuro Muscolar Omincenter
Neurology
NeuroMuscolar Omnicentre
Neuropsichiatria Infantile
Neuroriabilitazione
UOC Neuroriabilitazione Neurologica

Clinical trials at this site (43)

Search interface

An Open-Label Extension Study to Evaluate the Long-term Safety and Efficacy of BMN 351 in Participants with Duchenne Muscular Dystrophy Pending

2024-511656-41-00 Duchenne Muscular Dystrophy 4
A Phase 1/2a Dose-Escalating Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ARO-DM1 in Subjects With … Pending

2024-513579-42-00 Type 1 Myotonic Dystrophy 7
Usnoflast Neuromuscular Investigation for Treatment Efficacy in ALS (UNITE-ALS) Pending

2025-522580-15-00 Amyotrophic Lateral Sclerosis (ALS) 4
A Study of SGT-003 Gene Therapy in Duchenne Muscular Dystrophy Pending

2025-522949-22-00 Duchenne muscular dystrophy 5
Efficacy, Safety, and Tolerability of DYNE-101 in Participants with Myotonic Dystrophy Type 1 Pending

2025-522957-20-00 Myotonic Dystrophy Type 1 5
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Global Study with an Open-Label Extension to Evaluate the Efficacy and Safety of In… Pending

2025-523087-20-00 Duchenne muscular dystrophy 5
Pridopidine Phase 3 Study to Evaluate Efficacy and Safety in ALS (PREVAiLS) Recruiting

2025-524002-16-00 Amyotrophic Lateral Sclerosis 5 2026-05-12
A study to assess the efficacy and safety of empasiprubart in adults with CIDP Recruiting

2025-520805-10-00 Chronic inflammatory demyelinating polyneuropathy (CIDP 5 2026-03-12
A Global Phase 3 Open-Label Extension Study to Assess AOC 1001 in Patients with DM1 Recruiting

2025-520766-22-00 Myotonic Dystrophy Type 1 5 2026-01-21
A Study to Find Out How Nusinersen is Processed in the Body When Given Through the ThecaFlex DRx™ System in Adult and Pediatric Participants… Recruiting

2024-514239-21-00 Spinal Muscular Atrophy 3 2025-05-21
A Phase 3 Study to Evaluate AOC 1020 in Participants with FSHD Recruiting

2025-521012-18-00 Facioscapulohumeral Muscular Dystrophy (FSHD) 5 2026-04-13
A Study to Evaluate How Apitegromab Works in Subjects Who Are Less Than 2 Years Old and Have Spinal Muscular Atrophy Recruiting

2024-520130-29-00 Spinal Muscular Atrophy 4 2025-12-17
A Phase 2b Study of IMVT-1402 Treatment in CIDP Recruiting

2024-517614-14-00 Chronic Inflammatory Demyelinating Polyneuropathy (CIDP 4 2025-11-28
A Study of the Long-Term Safety and Efficacy of VX-670 in Patients With Myotonic Dystrophy Type I Recruiting

2024-517983-47-00 Myotonic Dystrophy 9 2025-11-25
An Open-Label Extension Study to Evaluate the Long-Term Safety and Efficacy of Once Daily Mexiletine PR in Patients with Myotonic Dystrophy … Recruiting

2024-511178-66-00 Myotonic Dystrophy type 1 and type 2 (DM1/DM2) 5 2025-09-12
A Study to Evaluate the Efficacy and Safety of DNTH103 in Adults with Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE) Recruiting

2024-517529-26-00 Chronic Inflammatory Demyelinating Polyneuropathy 5 2025-08-04
A 2-Part, Randomized, Double-Blind, Placebo-Controlled Study in Participants with Duchenne Muscular Dystrophy Amenable to Exon 44 Skipping t… Recruiting

2024-517584-23-00 Duchenne Muscular Dystrophy 9 2025-05-16
A randomized, phase II/III trial on the biological and clinical effects of acetyl-L-carnitine in ALS Recruiting

2023-509853-29-00 amyotrophic lateral sclerosis 10 2025-02-24
Study of ARO-DUX4 in Adult Patients With Facioscapulohumeral Muscular Dystrophy Type 1 Recruiting

2023-509748-89-00 Facioscapulohumeral muscular dystrophy (FSHD) 7 2025-02-19
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Investigate the Efficacy and Safety of Once Daily Mexiletine PR During… Recruiting

2024-511179-13-00 Myotonic Dystrophy type 1 and type 2 (DM1/DM2) 5 2025-01-13
A Phase 1/2 Study of VX-670 in Adult Subjects with Myotonic Dystrophy Type 1 Recruiting

2023-506028-10-00 Myotonic Dystrophy 7 2024-12-11
A Phase 2 Open-label (Core Phase Plus Extension Phase) With 2 Cohorts Study to Assess the Pharmacokinetics and Safety of Givinostat in DMD P… Recruiting

2024-511823-32-00 Duchenne muscular dystrophy (DMD) 4 2024-11-06
Phase 1/2a study of ATX-01 in participants with DM1 Recruiting

2023-505363-37-00 Myotonic dystrophy type 1 (DM1) 1 2024-08-12
A Study to Investigate the Pharmacokinetics (PK) and Safety of Risdiplam in Infants with Spinal Muscular Atrophy Recruiting

2023-505602-42-00 Spinal Muscular Atrophy (SMA) 4 2024-04-30